TGFB1 and neoplasm: Additionally, whereas numerous other signalling pathways are likely to contribute to the aggressive tumour phenotypes observed in patients, transcriptional profiling of our GEMMs identifies epithelial tumour cell-intrinsic TGFβ signalling as a potentially actionable, predictive biomarker in this setting.